China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
28.43
-0.15 (-0.52%)
May 8, 2026, 3:00 PM CST

SHA:600511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
7,81111,48210,88610,9268,8967,304
Trading Asset Securities
-----11.4
Cash & Short-Term Investments
7,81111,48210,88610,9268,8967,316
Cash Growth
-11.72%5.47%-0.36%22.81%21.60%17.53%
Accounts Receivable
17,72414,74313,93112,88112,55013,392
Other Receivables
384.21186.45199.01204389.6979.93
Receivables
18,10814,92914,13013,08512,94013,472
Inventory
5,1835,1924,9563,9613,7173,515
Other Current Assets
209.87388.21385.73307.79210.44280.62
Total Current Assets
31,31131,99130,35728,27925,76424,584
Property, Plant & Equipment
782.13778.96878.6827.04857.91845.06
Long-Term Investments
2,6462,4652,1761,9071,6231,365
Goodwill
203.77203.77203.77203.77203.77203.77
Other Intangible Assets
236.13243.1276.76258.11262.92258.65
Long-Term Deferred Tax Assets
162.22163.25149.07123.87124.37115.94
Long-Term Deferred Charges
143.81148.78152.39150.0686.1989.6
Other Long-Term Assets
690.56690.6734.85703.57686.95548.08
Total Assets
36,17636,68534,92832,45329,60928,010
Accounts Payable
12,24412,78512,08610,9439,91710,058
Accrued Expenses
104.56498.67536.83604.96640.01564.03
Short-Term Debt
196.57222.31485.06268.35252.06428.83
Current Portion of Leases
-102.11100.274.0880.575.81
Current Income Taxes Payable
94.3246.5487.49113.1784.89112.18
Current Unearned Revenue
66.7967.88275.2561.12176.943.68
Other Current Liabilities
1,5531,6801,2851,8301,5891,457
Total Current Liabilities
14,35515,40214,85613,89412,74012,739
Long-Term Leases
214.57191.86260.69205.08182.57197.29
Long-Term Unearned Revenue
32.5534.1838.7946.0646.3542.66
Pension & Post-Retirement Benefits
-0.190.270.440.450.54
Long-Term Deferred Tax Liabilities
16.717.824.1926.7833.4735.39
Other Long-Term Liabilities
730.82730.63773.55747.14747.14639.8
Total Liabilities
15,34916,37715,95314,92013,75013,655
Common Stock
754.5754.5754.5754.5754.5754.5
Additional Paid-In Capital
2,3492,3492,3492,3492,3492,349
Retained Earnings
15,86515,39013,99712,64211,0879,652
Comprehensive Income & Other
78.0750.9227.2830.7424.0424.91
Total Common Equity
19,04618,54517,12815,77614,21512,780
Minority Interest
1,7811,7641,8471,7571,6451,575
Shareholders' Equity
20,82720,30818,97517,53315,85914,355
Total Liabilities & Equity
36,17636,68534,92832,45329,60928,010
Total Debt
506.36516.28845.95547.5515.13701.93
Net Cash (Debt)
7,30410,96510,04010,3788,3816,614
Net Cash Growth
-8.57%9.22%-3.26%23.83%26.72%21.97%
Net Cash Per Share
9.6814.5313.3113.7611.118.77
Filing Date Shares Outstanding
754.48754.5754.5754.5754.5754.5
Total Common Shares Outstanding
754.48754.5754.5754.5754.5754.5
Working Capital
16,95716,58915,50114,38513,02511,845
Book Value Per Share
25.2424.5822.7020.9118.8416.94
Tangible Book Value
18,60618,09816,64815,31413,74812,318
Tangible Book Value Per Share
24.6623.9922.0620.3018.2216.33
Buildings
-408.84408.84408.84433.49387.18
Machinery
-830.63802.66759.8702.78661.15
Construction In Progress
--0.572.5436.2157.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.